What does GMP certification mean?

GMP certification means a manufacturing site has been audited by a national medicines authority (or equivalent) and operates under a documented quality system covering personnel training, facility hygiene, equipment qualification, raw material traceability, batch records, and product release procedures.

Which European countries lead in GMP-certified biotech?

Switzerland and Germany dominate by depth (Basel, Heidelberg, Mainz). Denmark adds large-scale aseptic capacity (Novo Nordisk). Lithuania has growing biologics GMP presence anchored by Northway Biotech. Poland brings competitive small-molecule and finished-dose GMP capacity.

What is the difference between GMP and ISO 13485?

GMP governs medicinal product manufacturing (drugs, biologics, APIs). ISO 13485 governs medical device and diagnostic manufacturing. Companies making combination products, drug-device combinations, or in-vitro diagnostics often hold both. Use the ISO-13485 filter for device-grade quality systems; use GMP for medicines.

How are GMP-certified companies verified in this directory?

Every profile is hand-reviewed: GMP claim must be supported by an official source — a national medicines agency listing, a published certificate, an inspector report, or operator documentation referencing a specific GMP scope. Self-claimed GMP without documentation does not earn the marker in this directory.

Compliance filter

GMP biotech companies in Europe — compliance directory

GMP (Good Manufacturing Practice) is the regulatory framework that governs the production of medicines, biologics, and active pharmaceutical ingredients. In the EU, GMP is enforced by national medicines agencies under EMA coordination; outside the EU, the FDA, MHRA, and equivalents apply parallel frameworks. This page lists biotech and pharma companies in the directory that publicly document GMP-aligned manufacturing — drug substance, drug product, fill-finish, biologics, and APIs — sourced from official certification disclosures, inspector reports, or operator documentation.

Evidence

Visible records24

Verified24

Countries covered4

Categories4

Avg sources / record0.0

Compliance view

Where is this standard strongest?

Germany (15), Denmark (5), Estonia (2), and Finland (2). Top cities: Copenhagen, Denmark (2), Darmstadt, Germany (2), Tartu, Estonia (2), and Berlin, Germany (1). Most visible records: Eckert & Ziegler, RHEACELL, Avantor / VWR Germany, and Kuehne+Nagel Healthcare Germany.

Compliance view

Which categories carry this standard?

Manufacturing (8), Therapeutics (7), CDMO (6), and Infrastructure anchor (3). Latest review: 15 March 2026. Review cycle: March 2026.

Compliance view

Why this standard matters

This page helps separate vague claims from records where the quality or regulatory marker is already visible in public evidence.

Compliance view

Related market brief

What the BIO CITY biotechnology city in Vilnius is, how Northway Biotech operates as the 2026 anchor tenant, which capabilities are live at BIO CITY Vilnius today, and how the multi-phase biotech city build-out is progressing — with sources.

Open related brief

Country breakdown

GMP companies by country

Count of companies with GMP-relevant quality systems, the strongest city in each country, and a sample operator you can open as an entry point.

Country	Companies	Top city	Sample operator
Germany	15	Darmstadt	Avantor / VWR Germany
Denmark	5	Copenhagen	ALK-Abelló
Estonia	2	Tartu	Icosagen Group
Finland	2	Helsinki	Nanoform Finland

Category breakdown

GMP companies by category

Categories carrying GMP-relevant quality systems, their count, and the strongest sample operator in each.

Category	Companies	Sample operator
Manufacturing	8	ALK-Abelló
Therapeutics	7	BioNTech SE
CDMO	6	IDT Biologika
Infrastructure anchor	3	Avantor / VWR Germany

Full list

GMP records

24 compliance records currently match the active filter.

Berlin radiopharma and isotope-products anchor spanning medical isotopes, radiation components, and nuclear-medicine supply.

Lead: Dr. Harald HasselmannChief Executive Officer
Scale: International isotope and radiopharma platform

Heidelberg regenerative-medicine company focused on stromal-cell therapies and clinical-stage cell-based products.

Lead: Dr. Christoph GanssPhysician, Chief Executive Officer and Founder
Scale: Clinical-stage regenerative-medicine platform

Darmstadt distribution node connecting German and Baltic operators to cleanroom consumables, bioprocess materials, and laboratory procurement infrastructure.

Lead: Silvia Orlitsch / Gregor OstrowiczManaging Directors, VWR International GmbH
Scale: German life-science distribution hub

German healthcare-distribution node linking GDP-aligned warehousing and pharmaceutical road logistics into the wider cluster.

Lead: Jörg WoykeGlobal Head of Road Logistics Healthcare
Scale: German healthcare road-logistics platform

Hauneck node connects healthcare transport execution to upstream bioprocess suppliers and cluster manufacturing programs.

Lead: Jörg WoykeGlobal Head of Road Logistics Healthcare
Scale: European supplier-logistics node

Tartu antibody-discovery and recombinant-protein platform now reinforced by a 1,600 m2 cGMP production facility and a broad partner network.

Lead: Mart UstavFounder and CEO
Scale: Clinical CDMO and cGMP protein manufacturing

Burghausen biosolutions and process-chemistry manufacturing anchor with large-scale industrial biotechnology and regulated process infrastructure.

Lead: Dr. Christian HartelPresident and Chief Executive Officer
Scale: Industrial and commercial manufacturing

Tübingen mRNA-development and translational-manufacturing anchor with a current executive record and a live RNA platform profile.

Lead: Alexander ZehnderChief Executive Officer
Scale: Clinical and translational development

Düsseldorf primary-packaging and drug-delivery systems anchor serving pharma and biotech manufacturing across Europe.

Lead: Uwe RöhrhoffInterim Chief Executive Officer
Scale: Global pharma industrial supply

Laupheim biologics CDMO anchor focused on mammalian production, late-stage development, and regulated commercial manufacturing.

Lead: Prof. Dr. Uwe BüchelerInterim Chief Executive Officer
Scale: Clinical-to-commercial CDMO manufacturing

Ravensburg aseptic-fill and injectable CDMO anchor operating one of Europe's most important sterile manufacturing networks.

Lead: Henryk Badack, Titus Ottinger, and Carsten PressManaging Directors
Scale: Global injectable CDMO manufacturing

Hørsholm allergy-immunotherapy headquarters and production-control node anchored in standardized vaccine manufacturing and quality systems.

Lead: Peter HallingPresident and Chief Executive Officer
Scale: Commercial specialty manufacturing

Kvistgaard vaccine-development and manufacturing anchor with commercial biodefense and travel-vaccine platforms operating inside a regulated global network.

Lead: Paul ChaplinPresident and Chief Executive Officer
Scale: Commercial vaccine manufacturing

Kalundborg is the flagship Danish industrial complex for API, biologics, and large-scale metabolic-disease manufacturing within Novo Nordisk's global network.

Lead: Lars Fruergaard JørgensenPresident and Chief Executive Officer
Scale: Global commercial manufacturing

Darmstadt science and technology platform spanning life-science process materials, bioprocess inputs, and laboratory infrastructure.

Lead: Belen GarijoChair of the Executive Board and Chief Executive Officer
Scale: Global life science manufacturing

Tartu API CDMO providing process chemistry, analytical development, scale-up, and GMP-oriented manufacturing support for small-molecule pharmaceutical programs.

Lead: Dr. Andrus TasaChairman of the Management Board
Scale: Clinical CDMO

Helsinki particle-engineering CDMO using proprietary nanoforming technology to improve drug solubility and move small-molecule programs from development into clinical and commercial supply.

Lead: Edward HaeggstromChief Executive Officer
Scale: Clinical to Commercial

Espoo-headquartered pharmaceutical company combining API production, formulation, and neuroscience-focused R&D with regulated Finnish manufacturing operations.

Lead: Liisa HurmePresident and CEO
Scale: Global Market

Copenhagen antibody-therapeutics headquarters running Genmab's platform-engineering, translational science, and late-stage oncology execution from its Valby base.

Lead: Jan van de WinkelPresident and Chief Executive Officer
Scale: Global Biopharma

German CDMO platform for viral vaccines, cell and gene therapy, and aseptic fill-finish manufacturing in Dessau-Rosslau. The verified March 2026 record ties the facility to current official executive leadership and live biologics production infrastructure.

Lead: Dr. Sally ChoeCo-CEO
Scale: Commercial biologics CDMO

Leverkusen pharmaceutical anchor spanning commercial therapeutics, process development, analytical quality, and global manufacturing coordination.

Lead: Bill AndersonChief Executive Officer
Scale: Global commercial manufacturing

German biopharmaceutical and small-molecule production titan spanning R&D, biologics, fill-finish, and global supply operations.

Lead: Hubertus von BaumbachChairman of the Board of Managing Directors
Scale: Global therapeutic manufacturing

Mainz mRNA and immunotherapy headquarters coordinating BioNTech's oncology pipeline, manufacturing network, and clinical execution ahead of the planned 2026 launch window.

Lead: Ugur SahinCEO and Co-Founder
Scale: Commercial Phase

Copenhagen-area neuroscience therapeutics company combining brain-disease R&D, regulated pharmaceutical supply, and global commercial operations.

Lead: Charl van ZylPresident and CEO
Scale: Global Supply

FAQ

Frequently asked questions

What does GMP certification mean?: GMP certification means a manufacturing site has been audited by a national medicines authority (or equivalent) and operates under a documented quality system covering personnel training, facility hygiene, equipment qualification, raw material traceability, batch records, and product release procedures.
Which European countries lead in GMP-certified biotech?: Switzerland and Germany dominate by depth (Basel, Heidelberg, Mainz). Denmark adds large-scale aseptic capacity (Novo Nordisk). Lithuania has growing biologics GMP presence anchored by Northway Biotech. Poland brings competitive small-molecule and finished-dose GMP capacity.
What is the difference between GMP and ISO 13485?: GMP governs medicinal product manufacturing (drugs, biologics, APIs). ISO 13485 governs medical device and diagnostic manufacturing. Companies making combination products, drug-device combinations, or in-vitro diagnostics often hold both. Use the ISO-13485 filter for device-grade quality systems; use GMP for medicines.
How are GMP-certified companies verified in this directory?: Every profile is hand-reviewed: GMP claim must be supported by an official source — a national medicines agency listing, a published certificate, an inspector report, or operator documentation referencing a specific GMP scope. Self-claimed GMP without documentation does not earn the marker in this directory.

Next step

Read the compliance filter, then move into cities and categories.

This page works best as a starting filter. For deeper comparison, use city, category, and methodology pages.

Open strongest city Open strongest category Open methodology Suggest a company

GMP biotech companies in Europe — compliance directory

Where is this standard strongest?

Which categories carry this standard?

Why this standard matters

Related market brief

GMP companies by country

GMP companies by category

GMP records

Eckert & Ziegler

RHEACELL

Avantor / VWR Germany

Kuehne+Nagel Healthcare Germany

Kuehne+Nagel Healthcare Hauneck

Icosagen Group

WACKER Biotech

CureVac

Gerresheimer

Rentschler Biopharma

Vetter Pharma

ALK-Abelló

Bavarian Nordic

Novo Nordisk Kalundborg

Merck KGaA

TBD Pharmatech

Nanoform Finland

Orion Corporation

Genmab A/S

IDT Biologika

Bayer Pharmaceuticals

Boehringer Ingelheim

BioNTech SE

H. Lundbeck A/S

Frequently asked questions

Read the compliance filter, then move into cities and categories.